Patents by Inventor Georges Morgant

Georges Morgant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTICAL USE OF TERNARY COMPLEXES OF VALPROIC ACID
    Publication number: 20160166705
    Abstract: A method of treating a human subject having a condition responsive to valproic acid therapy, includes administering to the subject an effective amount of a metal-based ternary complex of valproic acid with nitrogen donor ligands, in particular with diimines or diamines.
    Type: Application
    Filed: February 4, 2016
    Publication date: June 16, 2016
    Inventors: Maite SYLLA-IY ARRETA VEITIA, Francoise DUMAS, Georges MORGANT
  • Rhenium complexes and their pharmaceutical use
    Patent number: 8987491
    Abstract: The present invention is directed to a rhenium complex of general Formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X is Se; Y is NH, O or S or is a methylene group; Z is halogen; m=0, 1, or 2 and p=0, 1, or 2, provided that m and p are both different from zero when Y is NH, O or S; n=3; R? is a phenyl group or a group of general Formula —(CH2)q—COOH wherein q=1 or 2, a pharmaceutical composition comprising a therapeutically effective amount of at least one of such rhenium complex where X is additionally S or Te, a method for preparing said rhenium complex and a method for treating a proliferative growth related-disorder using a therapeutically effective amount of at least one of said rhenium complex where X is additionally S or Te. Also claimed is the use of compounds of formula (II) in the preparation of compounds of formula (I).
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: March 24, 2015
    Assignees: Societe de Coordination de Recherches Therapeutiques, Universite Paris-Sud 11, Centre National de la Recherche Scientifique
    Inventors: Philippe Collery, Jean D'Angelo, Georges Morgant
  • RHENIUM COMPLEXES AND THEIR PHARMACEUTICAL USE
    Publication number: 20130158109
    Abstract: The present invention is directed to a rhenium complex of general Formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X is Se; Y is NH, O or S or is a methylene group; Z is halogen; m=0, 1, or 2 and p=0, 1, or 2, provided that m and p are both different from zero when Y is NH, O or S; n=3; R? is a phenyl group or a group of general Formula —(CH2)q—COOH wherein q=1 or 2, a pharmaceutical composition comprising a therapeutically effective amount of at least one of such rhenium complex where X is additionally S or Te, a method for preparing said rhenium complex and a method for treating a proliferative growth related-disorder using a therapeutically effective amount of at least one of said rhenium complex where X is additionally S or Te. Also claimed is the use of compounds of formula (II) in the preparation of compounds of formula (I).
    Type: Application
    Filed: June 1, 2011
    Publication date: June 20, 2013
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-SUD 11
    Inventors: Philippe Collery, Jean D'Angelo, Georges Morgant
  • THERAPEUTICAL USE OF TERNARY COMPLEXES OF VALPROIC ACID
    Publication number: 20120142658
    Abstract: A method of treating a human subject having a condition responsive to valproic acid therapy, includes administering to the subject an effective amount of a metal-based ternary complex of valproic acid with nitrogen donor ligands, in particular with diimines or diamines.
    Type: Application
    Filed: June 8, 2009
    Publication date: June 7, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-SUD XI
    Inventors: Maite Sylla-Iy Arreta Veitia, Françoise Dumas, Georges Morgant